Health and Medical Devices News
Natus Medical Announces 2010 Second Quarter Financial Results
SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three and six months ended June 30, 2010. For the second quarter ended June 30, 2010, Natus reported revenue of $52.7 million, compared to $37.3 million reported in the comparable quarter of the previous year. Net income was $3.1 million, or $0.11 per diluted share, for the second quarter of 2010, compared with net income of $2.3 million, or $0.08 per diluted share, for the sec
…
ZOLL AED Plus and AED Pro Approved by Japan Medical Device Safety Division and Office of Medical Devices
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it has been granted approval by the Japanese Pharmaceutical and Medical Devices Agency (PMDA) to import and distribute the AED Plus® and AED Pro® in Japan. These products are automated external defibrillators that incorporate ZOLL’s real-time CPR feedback technology—Real CPR Help®—for rescuers to assist them in providing high-quali
…
Mobile Health Expo™ Launches Event to Focus on Convergence of the Mobile Technology and Healthcare Industries
AUSTIN, Texas--(BUSINESS WIRE)--Mobile Health Expo is the only event focusing on the convergence of mobile technology and healthcare across the entire mobile health ecosystem.
…
Covidien完成对Somanetics Corporation的收购
都柏林--(BUSINESS WIRE)--(美国商业资讯)--领先的全球性健康保健产品提供商Covidien（纽约证券交易所代码：COV）今天宣布，该公司已经完成了先前公布的以总价约2.50亿美元对Somanetics Corporation的收购（以净现金和短期投资支付）。 根据合并协议，Covidien旗下的间接全资子公司Covidien DE Corp.行使了其选择权，以每股25.00美元的要约收购价购买了Somanetics新发行的股票。在这项购买之后，Covidien DE Corp.拥有了足够的股票来实施与Somanetics的简易合并，Somanetics便成为了Covidien的间接全资子公司。此后，Somanetics普通股停止在纳斯达克全球市场（NASDAQ Global Market）交易。 关于Covidien Covidien是一家全球领先的健康保健产品公司，致力于为改善患者的用药效果提供创新的医疗解决方案，并通过在临床领域的领导地位及卓越表现创造价值。Covidien在三大业务领域制造和销售业界领先的产品线，并提供相应服务，这三大领域包括：医疗设备、医药产
…
Three Utah Luminaries to Be Inducted into UTC Hall of Fame
SALT LAKE CITY--(BUSINESS WIRE)--Dale H. Ballard, Gary L. Crocker and Michael O. Leavitt to be added to the list of renowned leaders and pioneers of the Utah Technology Industry.
…
Devax Receives CE Mark for the AXXESS™ Drug Eluting Bifurcation Stent
IRVINE, Calif.--(BUSINESS WIRE)--Devax Receives CE Mark for the AXXESS™ Drug Eluting Bifurcation Stent
…
Covidien Reports Third-Quarter 2010 Results
DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today reported results for the third quarter of fiscal 2010 (April - June 2010). Third-quarter net sales of $2.56 billion increased 2% from the $2.52 billion reported a year ago, with foreign exchange rate movement having no impact on the quarterly sales growth rate. Third-quarter 2010 gross margin of 55.6% rose 1.2 percentage points from the 54.4% of the prior-year period. This improvement reflected positive mix in the Medical Devices segment, b
…
Safeguard Scientifics Announces Second Quarter 2010 Financial Results
WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics Announces Second Quarter 2010 Financial Results; 2010 Aggregate Partner Company Revenue Guidance Increased, Expected to be between $325 Million and $350 Million
…
Riassunto: Covidien dichiara i risultati del terzo trimestre 2010
DUBLINO--(BUSINESS WIRE)--Covidien plc (NYSE: COV) ha dichiarato oggi i risultati del terzo trimestre dell'esercizio fiscale 2010 (aprile - giugno 2010). Le vendite nette del terzo trimestre sono state pari a 2,56 miliardi di dollari, con un aumento del 2% rispetto ai 2,52 miliardi dichiarati l'anno precedente; la variazione dei tassi di cambio non ha influito sul tasso di crescita delle vendite trimestrali. Il margine lordo del terzo trimestre 2010 è stato pari al 55,6%, con un aumento di 1,2 p
…
SYSPRO ERP Choice of Medical Device Start-Up
COSTA MESA, Calif.--(BUSINESS WIRE)--SYSPRO ERP Choice of Medical Device Start-Up
…
Research and Markets: Global Markets for Ultrasound Systems From 2009 Through to 2013
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5eb40c/global_markets_for) has announced the addition of the "Global Markets for Ultrasound Systems 2009-2013" report to their offering. The global ultrasound system market consists of the developed markets of the US and Europe (France, Germany, Italy, Spain, and the UK) as well as the emerging markets of Brazil, Russia, India, and China (BRIC). Maturity of the developed markets, combined with the ongoing g
…
Ortho Kinematics Launches Multi-Site Clinical Study of KineGraph VMA™
AUSTIN, Texas--(BUSINESS WIRE)--Ortho Kinematics, a privately held spine diagnostics company focused on revolutionizing spine motion analysis, announced today that it has begun a multi-site clinical study of the KineGraph VMA™, and that the initial 23 patients have been enrolled. The study will help determine which types of patients are best evaluated with KineGraph VMA testing. The KineGraph VMA is designed to provide functional diagnostic information to spine surgeons to be used in conjunction
…
Covidienがソマネティクス・コーポレーションの買収を完了
ダブリン--(BUSINESS WIRE)--（ビジネスワイヤ） -- ヘルスケア製品の供給で世界をリードするCovidien（NYSE: COV）は本日、先に発表していたソマネティクス・コーポレーションの買収を完了したと発表しました。対価は、正味現金および短期投資の取得額として総額約2億5000万ドルです。 合併契約の条項に従って、Covidienの間接完全子会社であるCovidien DE Corp.がソマネティクスの新規発行株式を1株当たりの公開買い付け価格25.00ドルで買い取るオプションを行使しました。買い取り後、Covidien DE Corp.はソマネティクスとの略式合併の成立に十分な株式を所有することとなり、ソマネティクスは従ってCovidienの間接完全子会社となりました。その後、ソマネティクス普通株式はナスダック・グローバル・マーケットでの取引を終了しました。 COVIDIENについて Covidienはヘルスケア製品の世界的大手企業として、患者転帰改善のための革新的メディカルソリューションを創出し、臨床でのリーダーシップと卓越性によって価値を提供しています。医療機
…
Bioject to Report Second Quarter 2010 Financial Results
PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, announced today that the Company will report its financial results for the second quarter ended June 30, 2010 on Wednesday, August 4, 2010, after the close of the financial markets. Management will conduct a conference call on Thursday, August 5, 2010 at 10:00 a.m. Eastern Daylight Time to review the results for the quarter. Ralph Makar, President and CE
…
NDS Surgical Imaging Launches Next-Generation ConnectOR™ G2 Informatics Platform
SAN JOSE, Calif.--(BUSINESS WIRE)--NDS Surgical Imaging Launches Next-Generation ConnectOR G2 Informatics Platform
…
Samenvatting: Op CZS gericht farmaceutisch bedrijf Lundbeck verlengt enterprise-contract met Medidata Solutions
NEW YORK--(BUSINESS WIRE)--CNS-focused pharmaceutical company Lundbeck extends enterprise contract with Medidata Solutions. The research intensive drug company extends agreement to use Medidata Rave in global clinical trials.
…
Response Biomedical Corporation Closes $8 Million Private Placement
VANCOUVER, British Columbia--(BUSINESS WIRE)--Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the “Company”) announced today that it has closed its previously announced private placement of common shares for gross proceeds of approximately $8 million. The Company issued 13,333,333 common shares at a price of C$0.60 per share. The purchasers are affiliates of OrbiMed Advisors, LLC. The shares issued under the private placement will have a hold period under Canadian law of four months an
…
iCAD Reports Second Quarter Financial Results
NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today reported financial results for the three and six months ended June 30, 2010. Financial highlights for the second quarter of 2010 include the following (all comparisons are with the second quarter of 2009): Total revenue of $6.1 million, compared with $5.7 million Digital computer-aided detection (CAD) and MRI CAD re
…
CardioNet, Inc. Reports Second Quarter 2010 Financial Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the second quarter ended June 30, 2010. Second Quarter Highlights Appointed Joseph H. Capper as President and Chief Executive Officer Achieved gross margin of 63% on revenues of $32 million Improved operating results with a loss of $0.09 per diluted share, a $0.14 improvement over t
…
Greatbatch, Inc. Reports 2010 Second Quarter Results
CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB), today announced results for its second quarter ended July 2, 2010: Sales grew 5% to $140.8 million driven by recoveries in Vascular and Electrochem revenues. Adjusted operating margin improved to 12.7% reflecting higher sales and continued R&D investment. GAAP diluted EPS of $0.33 per share and adjusted diluted EPS of $0.40 per share. Strong cash flows from operations allowed company to pay down $30 million of debt. Affirms full y
…
